Dermatology News

• Biologics Reduce COVID-19 Hospitalization Risk in Psoriasis Biologic treatment in patients with psoriasis is associated with a reduced risk of COVID-19-related hospitalization, compared with non-biologic systemic therapies, according to a new registry study.
  Reuters Health Information, October 27, 2020
• Abatacept as Treatment for Diffuse Cutaneous Systemic Sclerosis 'Exploratory outcome measures during the open-label extension, including the composite ACR CRISS score, indicate that abatacept might promote overall global improvement in these participants.'
  Medscape Medical News, October 28, 2020
• Study Shows Baricitinib Reduces Adult Atopic Dermatitis Severity Signs and symptoms of moderate to severe atopic dermatitis were significantly reduced with baricitinib 4 mg on top of topical corticosteroids, compared with placebo in the phase 3, BREEZE-AD7 study.
  Medscape Medical News, October 26, 2020
• Risankizumab Improves Patient-Reported Outcomes in Moderate to Severe Psoriasis Risankizumab treatment significantly improves symptoms, health-related quality of life and mental health among patients with moderate to severe psoriasis, according to findings from two randomized clinical trials.
  Reuters Health Information, October 22, 2020
• Local Estrogen Therapy for Vaginal Atrophy Can Start Before or After Age 60 Treatment with low-dose local estrogen therapy (ET) to improve symptoms of vaginal atrophy may start before or after age 60, according to a post-hoc analysis of a randomized, placebo-controlled trial in the US and Canada.
  Reuters Health Information, October 21, 2020
• 25 Drugs, Drug Classes Added to FDA's Safety Signal List The agency found a potential safety problem in a diabetes drug class. Several proton pump inhibitors and fibric acid derivatives also made the list.
  Medscape Medical News, October 21, 2020
• Dermatitis Herpetiformis May Be Common in Patients With Celiac Disease As many as 8% of patients with celiac disease (CD) may also have dermatitis herpetiformis (DH), and these patients are less likely to receive counseling on gluten-free diets, suggests an online survey.
  Reuters Health Information, October 20, 2020
• Non-Whites Sorely Underrepresented in Phase 3 Psoriasis Trials Participation by non-White patients in phase 3 therapeutic trials for plaque psoriasis is less than 15%.
  Medscape Medical News, October 21, 2020
• Cold-Chain-Independent Gel Could Deliver Antibiotics for Outer-Ear Infections With One Application Researchers have developed a new single-application drug-delivery system for treating outer-ear infections that does not require refrigeration.
  Reuters Health Information, October 20, 2020
• Women Make Progress in Pediatric Dermatology Leadership The researchers reviewed data on society leadership, research grants, and annual meeting speakers in order to evaluate the impact of women in pediatric dermatology.
  Medscape Medical News, October 21, 2020
• FAAM-EUROBAT 2020 Food Allergy Testing for Eczema in Kids Varies By Specialty A child with eczema will more likely be sent to get food allergy tests if she sees an allergist or a pediatrician and less likely if she sees a general practitioner or dermatologist.
  Medscape Medical News, October 19, 2020
• FAAM-EUROBAT 2020 Nasal Test for Shrimp Allergy Safe and Predictive A shrimp allergy test delivered with a dab of shrimp extract in the nose is safe and reliable, Barcelona researchers report.
  Medscape Medical News, October 17, 2020
• Joint Commission Issues Telehealth Safety Advisory However, the advisory focuses mostly on the pandemic and leaves out a big chunk of what affects safe practices in virtual encounters.
  Medscape Medical News, October 16, 2020
• Outpatient Visits Rebound for Most Specialties to Pre-COVID Levels Dermatology saw the largest increase, while pulmonology visits were still down 20% from early March.
  Medscape Medical News, October 16, 2020
• New Technologies Show Promise for Treating Pigmented Lesions Picosecond and nanosecond lasers are far more effective for treating individual lentigines compared with other types of devices, but ultrashort pulses carry a higher risk for postinflammatory hyperpigmentation.
  Medscape Medical News, October 16, 2020
• Guselkumab Improvements for PsA Persist Through 1 Year The findings extend the previously published 24-week primary endpoint results of the trial, which tested guselkumab for adults with PsA who had not previously taken a biologic drug.
  Medscape Medical News, October 16, 2020
• Has Trump’s Case Affected Your Impression of COVID-19? Just over a week after President Trump announced he had tested positive for SARS-CoV-2 infection, the White House doctor said the president was 'no longer considered a transmission risk to others.'
  Medscape Reader Polls, October 16, 2020
• Scrubs Ad That Insulted Women and DOs Pulled After Outcry Model wearing a 'DO' tag clipped to her scrubs carries a 'Medical Terminology for Dummies' book upside down. The company removed the ad and issued an apology on social media after widespread outrage.
  Medscape Medical News, October 14, 2020
• Physician-Mother Investigates Son's Mysterious Illness A cardiologist and mother used every resource and connection she had to investigate strange symptoms in her 9-year-old son.
  Medscape Medical News, October 13, 2020
• Hidradenitis Suppurativa Therapy Options Should Be Patient Guided A modern approach to hidradenitis suppurativa that incorporates such strategies as lasers, marsupialization, and metformin is built on a strategy individualized to the patient's most challenging symptoms.
  Medscape Medical News, October 13, 2020